SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-054040
Filing Date
2024-04-29
Accepted
2024-04-29 16:16:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A tm2412602d1_s3a.htm S-3/A 68933
2 EXHIBIT 4.5 tm2412602d1_ex4-5.htm EX-4.5 288787
3 EXHIBIT 4.6 tm2412602d1_ex4-6.htm EX-4.6 311024
  Complete submission text file 0001104659-24-054040.txt   670075
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-278334 | Film No.: 24891001
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)